I got 13 UTIs in one year. I took the cranberry pills. The expensive ones, the drugstore ones, the powders, the gummies. None of it worked.
It turned out cranberry wasn't the problem. The form of cranberry I was taking was. Every product I tried used insoluble PACs from whole-berry blends or pomace, the part of the cranberry that doesn't actually reach your bladder in active form. I was paying for cranberry. I just wasn't getting the molecule that prevents UTIs.
That distinction is the central finding of a 2022 clinical study in the Journal of Dietary Supplements by Amy Howell, the researcher who first identified A-type proanthocyanidins as the active anti-adhesion compound in cranberry. Her study compared two commercial cranberry supplements head-to-head and confirmed what most consumers don't realize: PAC solubility determines whether your cranberry pill actually works.andh
Here's what the research found, what to look for in a UTI prevention supplement, and what to avoid in the cranberry aisle.
What the 2022 Howell Study Found
The Howell study compared two real cranberry supplements available to consumers: one made from cranberry juice extract, and one made from a whole cranberry blend (juice plus pomace, the leftover pulp, skins, and seeds).
Both products were chromatographically separated into their polyphenol, sugar, and acid fractions, and tested for anti-adhesion activity against uropathogenic E. coli, the strain that causes most UTIs.
The findings:
Only fractions containing soluble PACs produced meaningful anti-adhesion activity. Insoluble PACs, the ones bound up in fiber and pomace, did not.
The cranberry juice extract product had tenfold higher soluble PAC content than the whole-berry blended product, which contained mainly insoluble PACs.
After daily consumption over a one-week intervention, the juice extract product produced significantly higher urinary anti-adhesion activity than the whole-berry product.
Translation: where the PACs come from and whether they're soluble determines whether they end up active in your urine, which is where they actually need to be to prevent UTIs.
What "Soluble A-Type PAC" Actually Means
PACs (proanthocyanidins) are polyphenol compounds found in many plants. Two structural forms exist:
A-type PACs. Found in cranberries, blueberries, and a few other plants. Their unique molecular bonds prevent E. coli from sticking to bladder walls. This is the form that prevents UTIs.
B-type PACs. Found in grape seed, apple, chocolate, and pine bark. These are antioxidants but lack the anti-adhesion structure. They don't prevent UTIs.
Soluble PACs. Free in solution, able to be absorbed and reach the urinary tract.
Insoluble PACs. Bound up in plant fiber and pomace. They pass through your digestive tract largely unabsorbed.
For UTI prevention, you need soluble A-type PACs. Anything else is either not the right molecule, or not in a form that reaches your bladder.
For the full scientific history of how researchers identified A-type PACs as the active mechanism (and how cranberry traveled from Indigenous medicine to molecular biology), see Dr. Meg's deep dive: Cranberry: From Ancestral Medicine to Molecular Science.
Establishing the Clinical Dose
Multiple clinical trials, including the meta-analyses underpinning the 2023 Cochrane Review on cranberry for UTI prevention, identify 36mg of A-type PACs per day as the threshold for clinically meaningful UTI prevention.
This is measured by the BL-DMAC method, the standardized lab assay for quantifying A-type PACs specifically. Without DMAC verification, there's no reliable way to know what's actually in the bottle.
Most drugstore cranberry supplements don't disclose their DMAC-verified PAC content. Some list "cranberry extract" with proprietary blends. Some use powder at concentrations of less than 2% PACs by weight, meaning a 500 mg capsule of powder might deliver 5 to 10 mg of PACs, well below the clinical threshold.
If a product doesn't list a specific milligram amount of A-type PACs verified by DMAC testing, the math probably doesn't add up.
How Much Cranberry Juice Would It Take?
The cranberry juice you find at the grocery store contains less than 1 mg of PACs per serving, often closer to 0.1 mg in cranberry cocktail products that are mostly water and sugar.
To reach the 36mg clinical threshold from juice alone, you'd need to drink roughly 32 ounces of pure unsweetened cranberry juice every single day. That's a lot of pee. And unsweetened cranberry is punishingly tart. Consequently most commercial cranberry juice contains a boatload of added sweeteners that can disrupt the vaginal microbiome and feed yeast.
Cranberry juice is great for your Cosmo. It is not, in any meaningful sense, a good UTI prevention strategy.
The Bioavailability Problem
Dose alone doesn't tell you whether a supplement works. A bottle that lists 100 mg of an active compound on the label is meaningless if the compound never reaches the tissue where it needs to act. This is the bioavailability problem, and it's the reason most cranberry supplements fail even when their PACs numbers look impressive on paper.
Bioavailability is the percentage of an ingested compound that actually reaches systemic circulation in active form. For a UTI prevention supplement, the relevant question is more specific: what percentage of the PACs you swallow actually reach your urinary tract in active form, with their anti-adhesion structure intact, at concentrations high enough to block E. coli from sticking to your bladder wall?
For most cranberry supplements, the answer is very little.
There's also a deeper layer to this story: gut bacteria break soluble PACs down into smaller compounds (valeric acid derivatives, valerolactones, and other small phenolic metabolites) that are absorbed and excreted into urine, where they block bacterial adhesion. The bioavailability question is therefore also partly a microbiome question. For the full picture, see Your Bladder Health Starts in the Gut.
What Reduces PAC Bioavailability
Insoluble PAC source. PACs bound up in pomace (skins, seeds, fiber) pass through your digestive tract largely unabsorbed. The Howell 2022 study confirmed that whole-berry blends, despite often having higher total PAC counts on the label, deliver lower urinary anti-adhesion activity than juice extracts because so much of the PAC content is structurally locked into insoluble plant matter.
Poor formulation. Many cranberry supplements add fillers, binders, and excipients that interfere with absorption. Glycerin, magnesium stearate at high concentrations, and certain proprietary "delivery systems" can reduce the percentage of active compound that reaches circulation. The supplement industry is largely unregulated on this point, and "absorption-enhanced" or "high-bioavailability" claims rarely come with the testing data to back them up.
What Bioavailability Looks Like When Done Right
The supplement industry has plenty of products with impressive labels and weak performance. The signals that distinguish supplements that actually work from supplements that don't are specific:
DMAC-verified A-type PAC content. Not "cranberry extract." Not "cranberry concentrate." A specific milligram amount of A-type PACs verified by the BL-DMAC method, listed on the label.
Soluble form. PACs from juice extract or specifically standardized soluble fractions, not whole-berry blends or pomace-laden formulations.
Third-party testing. Independent lab verification that the product actually contains what the label claims, batch by batch. Companies that test with NSF, USP, or independent labs and publish results are demonstrating that they care about delivering on their claims rather than just making them.
Single source identity. Cranberry from Vaccinium macrocarpon (the North American cranberry species used in clinical research), not unspecified cranberry blends that may include lower-PAC species or wild-harvested material with no quality control.
Functional dose. At least 36mg of DMAC-verified A-type PACs per daily serving, the threshold supported by the meta-analyses on UTI prevention.
UTI Biome Shield was formulated against this checklist. With 38mg of DMAC-verified A-type PACs per capsule, a soluble juice-extract source, Vaccinium macrocarpon species identity, and a multi-mechanism formulation it is specifically designed to deliver bioavailable, active compound to the urinary tract rather than impressive label numbers that don't translate to clinical effect.
Red Flags in UTI Supplements
- Vague ingredient lists. "Cranberry blend" or "proprietary formula" with no specific milligrams of A-type PACs.
- B-type PACs from grape seed or apple extract instead of true cranberry.
- Glycerin, added sugars, or juice powder filler.
- Excessive fillers. Magnesium stearate, talc, artificial colors.
- Unrealistic claims like "cures UTIs" or "instant relief." Supplements prevent, they don't cure.
- No third-party testing or GMP certification.
UPEC Versus Other Bacteria
Cranberry PACs have their strongest and best-studied effect against Uropathogenic E. coli (UPEC) because they interfere with bacterial adhesion, particularly P-Type and Type 1 fimbriae-mediated attachment to the urinary tract. Since E. coli causes approximately 80-90% of uncomplicated recurrent UTIs, that's a very important mechanism. Some in vitro work suggests cranberry constituents may affect other organisms through anti-adhesion, biofilm, quorum sensing or other virulence mechanisms, but this evidence is weaker than it is for E. coli. If you're taking a clinical-dose cranberry product and still experiencing recurrent UTIs, ask your doctor for a urine culture to identify the specific bacteria. For symptoms that persist despite negative culture results, modern PCR testing can detect pathogens that traditional cultures miss. For more on the diagnostic side of recurrent UTI care, see Why Modern PCR Testing Is Revolutionizing UTI Care.
Cranberry is also a prevention tool, not a treatment. If you have an active UTI, see a doctor. Antibiotics remain the standard of care for active infections.
Soluble A-Type PACs Are Science Backed. Everything Else Is Marketing.
The reason your cranberry supplement might not be working isn't that cranberry doesn't prevent UTIs. The 2022 Howell study, the 2023 Cochrane Review of 50 clinical trials, and three decades of research all confirm that the right form of cranberry significantly reduces UTI recurrence.
The reason most products fail is that they use the wrong form: insoluble PACs trapped in pomace, B-type PACs from grape seed, or undisclosed doses of unverified extract.
Look for soluble A-type PACs from Vaccinium macrocarpon, DMAC-verified, at 36mg or higher. Combine that with D-mannose, vitamin D3, zinc, and whole-fruit polyphenols for multi-mechanism protection. That's the winning formula.
Your bladder, and your wallet, will thank you.
Related Reading
For more on the science, prevention, and broader context behind UTI Biome Shield:
Cranberry: From Ancestral Medicine to Molecular Science — Dr. Meg's deep dive on how cranberry traveled from Indigenous medicine through 1970s women's health movements to modern molecular research on A-type PACs.
Your Bladder Health Starts in the Gut — How the gut-bladder axis explains why microbiome health affects urinary tract health, including why PAC metabolites matter more than intact PAC molecules.
Are UTI Preventive Antibiotics Worth It? — Why the 2025 AUA guideline now recommends discussing non-antibiotic prevention first, with the same 13-UTI founder story behind why this argument matters.
Why Modern PCR Testing Is Revolutionizing UTI Care — When anti-adhesion isn't enough: accurate diagnostics for non-E. coli pathogens and antibiotic resistance.
Antimicrobial Resistance Is a Women's Health Issue — The broader public health context for why non-antibiotic prevention isn't just a personal choice but a category-defining shift in recurrent UTI care.
UTI Prevention vs. UTI Treatment: What's the Difference? — The decision-tool guide to figuring out which strategy applies to your current situation.
Frequently Asked Questions
Why isn't my cranberry supplement working?
The most common reason is that the cranberry product doesn't contain soluble A-type PACs at the clinical dose. Most cranberry supplements use whole-berry blends or pomace that contain mostly insoluble PACs, which don't reach the urinary tract in active form. Others use juice powder at low concentrations, delivering far less than the 36mg of A-type PACs research shows is needed for meaningful UTI prevention. If your product doesn't list a specific DMAC-verified milligram dose of A-type PACs, you may not be getting a clinical dose.
What's the difference between A-type and B-type PACs?
A-type proanthocyanidins (found mainly in cranberries) have a unique molecular bond that prevents E. coli from sticking to bladder wall cells. This is the only form clinically shown to prevent UTIs. B-type PACs (found in grape seed, apple, chocolate, and pine bark) are antioxidants but lack the anti-adhesion structure. Some cranberry supplements blend in cheaper B-type PACs from other sources, which doesn't help with UTI prevention even though the bottle says "PACs."
What does DMAC-verified mean?
DMAC (4-dimethylaminocinnamaldehyde) is the standardized laboratory assay used to specifically measure A-type proanthocyanidins. Without DMAC verification, supplement labels can claim "PACs" without specifying the type, the dose, or the bioavailability. DMAC testing is the only reliable way to know that a product actually contains the form and dose of PACs shown to prevent UTIs.
What is bioavailability and why does it matter for cranberry supplements?
Bioavailability is the percentage of an ingested compound that reaches the relevant tissue in active form. For cranberry, the question is what percentage of the PACs you swallow actually reach your urinary tract in active form, with their anti-adhesion structure intact, at concentrations high enough to block E. coli adhesion. Most cranberry supplements have low PAC bioavailability because they use insoluble pomace-based PACs that pass through the digestive tract unabsorbed, lack standardization that would confirm the active compound is actually present, or use formulations with fillers and excipients that interfere with absorption. The Howell 2022 study confirmed that even when total PAC counts look similar on paper, soluble juice-extract sources deliver significantly higher urinary anti-adhesion activity than whole-berry blends.
How much cranberry do I need for UTI prevention?
Clinical research identifies 36mg of A-type PACs per day as the threshold for meaningful UTI prevention. UTI Biome Shield delivers 38mg of DMAC-verified soluble A-type PACs per capsule. Most over-the-counter cranberry supplements contain less than 5mg, far below the clinical threshold. Cranberry juice cocktail contains less than 1mg per serving, which is why drinking juice isn't a viable prevention strategy.
Does cranberry juice prevent UTIs?
Not at typical consumption levels. To reach the 36mg clinical threshold from juice alone, you would need to drink roughly 32 ounces of pure unsweetened cranberry juice every day. Most commercial cranberry juice is mostly water and added sugar, with even lower PAC content. Most cranberry juice is a beverage, not a UTI prevention strategy.
Are whole-berry cranberry supplements better than extract?
Counterintuitively, no. The 2022 Howell study showed that whole-berry blended supplements contain mostly insoluble PACs, which don't reach the urinary tract in active form. Cranberry juice extract powders that concentrate soluble A-type PACs produced markedly higher urinary anti-adhesion activity than whole-berry blends. "Whole fruit" sounds wholesome but doesn't translate to clinical effectiveness for UTI prevention.
What should I avoid in a UTI supplement?
Vague ingredient lists ("cranberry blend," "proprietary formula") that don't specify milligrams of A-type PACs. Products using B-type PACs from grape seed or apple instead of cranberry. Glycerin and added sugars. Excessive fillers like magnesium stearate. Unrealistic claims like "cures UTIs" or "instant relief." Products without third-party testing or GMP certification.
How quickly does the right cranberry supplement work?
Bacterial anti-adhesion activity in the urinary tract becomes measurable within 4 to 6 hours of taking a clinically dosed PAC supplement and continues for up to 12 hours. Daily dosing maintains protective levels around the clock. For UTI recurrence reduction, meaningful effects build over 8 to 12 weeks of consistent daily use, which matches the typical length of UTI prevention clinical trials. For reliable pre-trigger dosing consider adding in a short acting anti-adhesion compound like d-mannose.
